Excitatory amino acids can modify the tone of ce rebral vessels and permeability of the blood-brain barrier (BBB) by acting directly on endothelial cells of cerebral vessels or indirectly by activating receptors expressed on other brain cells. In this study we examined whether rat or human cere bromicrovascular endothelial cells (CEC) express ionotropic and metabotropic glutamate receptors. Glutamate and the glu tamate receptor agonists N-methyl-d-aspartate (NMDA), Cl am in 0-3 -hydroxy -5 -meth y 1i soxazole-4-propionic acid (AMPA), and kainate failed to increase [Ca2+li in either rat or human microvascular and capillary CEC but elicited robust responses in primary rat cortical neurons, as measured by fura-2 fluorescence. The absence of NMDA and AMPA recep tors in rat and human CEC was further confirmed by the lack of immunocytochemical staining of cells by antibodies specific for the AMPA receptor subunits GluRI, GluR2/3, and GluR4 and the NMDA receptor subunits NRI, NR2A, and NR2B. We failed to detect mRNA expression of the AMP A receptor sub units GluR I to GluR4 or the NMDA receptor subunits NRI\xx, NRloxx ' and NR2A to NR2C in both freshly isolated Whereas the roles of glutamate in regulating physi ological responses (Collingridge and Singer, 1990) and mediating excitotoxic injury (Meldrum and Garthwaite, 1990; Small and Buchan, 1996) to neurons have been Abbreviations used: IS, 13R-trans-ACPD, l-amino-cyciopentyl-lS, 3R-dicorboxylate; AMP A, Ct -amino-3-hydroxy-S-methyl-isoxazole-4propionic acid; BBB, blood-brain barrier; CEC, cerebromicrovascular endothelial cells; IP3, inositol trisphosphate; NMDA, N-methyl-D aspartate; PBS, phosphate-buffered saline; RT -PCR, reverse transcrip tase polymerase chain reaction. 396 rat and human microvessels and cultured CEC using reverse transcriptase polymerase chain reaction (RT-PCR). Cultured rat CEC expressed mRNA for KAI or KA2 and GluR5 subunits. Primary rat cortical neurons were found to express GluRI to GluR3 and NRI, NR2A, and NR2B by both immunocytochem istry and RT-PCR and KAI, KA2, GluR5, GluR6, and GluR7 by RT-PCR. Moreover, the metabotropic glutamate receptor agonist l-amino-cyclopentyl-IS, 3R-dicorboxylate (IS,3R trans-ACPD), while eliciting both inositol trisphosphate and [Ca2+li increases and inhibiting forskolin-stimulated cyclic AMP in cortical neurons, was unable to induce either of these responses in rat or human CEC. These results strongly suggest that both rat and human CEC do not express functional gluta mate receptors. Therefore, excitatory amino acid-induced changes in the cerebral microvascular tone and BBB perme ability must be affected indirectly, most likely by mediators released from the adjacent glutamate-responsive cells.
established, the possible involvement of glutamate in modulating cerebrovascular functions is less clear. Nu merous reports have described various modes of vasoac tive action of glutamate agonists or antagonists in differ ent segments of the cerebral vasculature in vivo and on isolated vessels (Fukuda et aI., 1983; Cavazutti et aI., 1987; Busija and Leffler, 1989; Perkins et aI., 1989; Faraci and Breese, 1993; Wendling et aI., 1994) . Studies using isolated cerebral microvessels reported that bovine and ovine cerebral microvessels lack binding sites for the N-methyl-D-aspartate (NMDA) antagonists 2-amino-5phosphonopentanoic acid, ketamine, MK-801, and dex trorphan (Beart et aI., 1988; Wendling et aI., 1996) , whereas Koenig et aI. (1992) suggested that capillary NMDA receptors may regulate blood-brain barrier (BBB) breakdown through the activation of a polyamine cascade. However, none of these studies was able to resolve the issue of the primary site(s) of action of glu tamate in the cerebral vasculature.
Due to the anatomical proximity of glutamate releasing neurons to the cerebral capillaries and mi crovessels, the presence of glutamate receptors on cere bromicrovascular endothelial cells (CEC) could signifi cantly affect vasomotor responses of the cerebral microvascular bed or the function of the BBB. Brain capillary and microvascular endothelial cells have been shown to express receptors for other neurotransmitters including noradrenaline (Bacic et aI., 1992) , serotonin (Cohen et aI., 1995) , acetylcholine (Linville et aI., 1995) , and dopamine (Bacic et aI., 1991) as well as for the vasoactive mediators histamine (Stanimirovic et aI., 1994a) , adenosine (Stanimirovic et aI., 1994a) , endothe lins (Stanimirovic et aI., 1994b) , bradykinin (Stan imirovic et aI., 1996b) , and angiotensins (Stanimirovic et aI., 1996a) . These neurotransmitters/mediators have also been shown to modulate both vascular tone (Luscher, 1990 ) and BBB permeability (Guillot and Audus, 1991; Stanimirovic et aI., 1996a) by acting on endothelium expressed receptors.
The purpose of this study was to determine if CEC express glutamate receptors on their membranes and are therefore the primary site of action for modulation of BBB permeability and/or vascular tone by glutamate in the cerebromicrovascular bed. We studied the presence of functional glutamate receptors in both freshly isolated rat and human capillaries and microvessels and cultured 
MATERIALS AND METHODS

Chemicals and reagents
All culture media and fetal bovine serum were obtained from GibcoBRL (Gaithersburg, MD, U.S.A. 
Freshly isolated cerebral microvessels
Rat brain microvessels and human brain capillaries or resis tance microvessels were isolated using a modification(s) of the procedures of Diglio et al. (1982) and Gerhart et al. (1988) , respectively. Rat brain microvessels were isolated from cortical brain tissue of four to six adult rats. Human brain capillaries and microvessels were obtained from small samples of human temporal lobe excised surgically from patients treated for idio pathic epilepsy.
In both cases, the brain samples were cleaned of pia matter and associated surface vessels, and cortical gray matter was dissected. The tissue was minced with scissors and homog enized in a glass-teflon homogenizer. The homogenate was passed once through 350-lLm and twice through 112-lLm mesh nylon nets (Nitex; Tetko, Elmsford, NY, U.S.A.) fitted in Mil lipore filter holders. Resistance micro vessels were dislodged from the 112-lLm mesh and collected in cold medium M199 (containing Earle's salts, 25 mmollL N-2-hydroxy ethylpiperazine-N' -2-ethanesulfonic acid, 4.35 gIL sodium bi carbonate, and 3 mmollL L-glutamine). Filtrates were subse quently centrifuged at 1,000 g for 10 minutes, and pellets were resuspended in 20 mL of 20% dextran (MW 70,000; Sigma) and centrifuged at 3,000 g for 15 minutes in a swinging bucket rotor. The pellets were dissolved in cold medium M199, and the microvessels and capillaries were collected on a 20-lLm mesh nylon net. Microvessels retained on the 20-lLm mesh were dislodged, washed three times in M199, and either used fresh or further processed to obtain endothelial cultures.
Cerebral endothelial cell cultures
Freshly isolated brain microvessels were enzymatically dis sociated to obtain endothelial cell cultures as follows: The re sistance vessels (112 to 350 ILm) and the capillaries and smaller microvessels (>20 ILm) derived from human brain samples were separately dissociated by exposure to 1 mg/mL type IV collagenase for 15 minutes at 37°C, centrifuged at 500 g for 5 minutes, resuspended in growth medium containing 65% me dium M199, 10% fetal calf serum, 5% human serum, 20% murine melanoma cell (mouse melanoma, Cloudman S91, clone M-3, melanin-producing cells)-conditioned medium, 5 ILg/mL insulin, 5 lLg!mL transferrin, 5 ng/mL selenium, and 10 ILg/mL endothelial cell growth supplement, seeded in 0.5% gelatin-coated plastic tissue culture dishes, and maintained at 37°C in an atmosphere of 5% CO 2 in air. Microvessels of rat brain retained on the 20-lLm mesh were dissociated by a brief 
Rat cortical neurons
Rat cortical neurons were cultured by a previously described method (Durkin et a!., 1997) . For RT-PCR and the determina tion of IP3 production, the cells were plated on polY-L-lysine 
[Ca 2 +]i measurement
To determine [Ca2+]i' human and rat CEC were cultured in complete medium on 24-mm glass coverslips coated with 10 j..l g/mL human fibronectin and 0.5% rat tail collagen, respec tively, for 1 to 4 days, while primary fetal rat cortical neurons were grown for 15 days on polY-L-lysine-coated coverslips. 
Inositol trisphosphate determination
To determine inositol phosphate formation, confluent rat CEC, human CEC, and primary cultures of rat cortical neurons grown in 35-mm petri dishes were prelabeled with eHjmyo inositol (2.5 mCilmL) for 16 to 18 hours in serum-and inositol free medium M199. Unbound [ 3 H]myo-inositol was removed by washing in M199, and the cells were then exposed to glu tamate and/or glutamate receptor agonists/antagonists in M199
in the presence of 20 mmollL LiCI (Berridge et a!., 1982) for 15 minutes. The reaction was stopped by replacing the medium with cold 0.3 mollL trichloroacetic acid, and the cells were scraped, briefly sonicated, and sedimented by centrifugation.
Aliquots of the supernatants were treated three times with an hydrous diethyl ether, the aqueous phases were separated by centrifugation, and the remaining ether was evaporated under nitrogen. The samples were neutralized with 6.25 mollL so dium tetraborate and applied to a 1-mL Dowex-AG lX8formate form anion exchange column. Inositol phosphate frac tions were eluted from the columns and quantified as previ ously described (Stanimirovic et aI., 1994b) . The IP3 fraction determined by this technique represents a mixture of IP3 iso mers.
Cyclic AMP determination
To determine levels of cyclic AMP in rat and human CEC and rat cortical neurons, cells grown in 24-well tissue culture plates were treated with the metabotropic glutamate receptor agonist IS,3R-trans-ACPD, alone or in combination with for skolin, in phosphate-buffered saline (PBS) containing 0.2%
bovine serum albumin and 1 mmollL 3-isobutyl-l-methyl xanthine for 10 min. The reaction was stopped by removing the reaction mixture and adding 65% (vol/vol) ice-cold ethanol.
The ethanol extraction was repeated twice, and the combined extracts were collected into test tubes and dried in a vacuum oven at 80°C. The cyclic AMP levels were determined using a commercial cyclic AMP enzyme immunoassay kit (Biotrak;
Amersham). The assay is based upon the competition between unlabeled cyclic AMP and a fixed quantity of peroxidase labeled cyclic AMP for a limited number of binding sites on a cyclic AMP-specific antibody.
Immunohistochemical detection of glutamate receptor subunits
Cells grown on glass coverslips were washed briefly in PBS and then immersed in Lana ' s fixative [4% paraformaldehyde and 14% (vol/vol) saturated picric acid in 0.25 mol/L NaH 2 P04, pH 6.9] for 1 hour at room temperature. The cells were then rinsed in PBS, permeabilized for 5 minutes in 0.25%
Triton X-IOO in PBS, and then rinsed 2 x 5 min with PBS.
Coverslips were inverted onto droplets of 5% normal donkey serum in 1 % bovine serum albumin (Sigma) in PBS for 40 minutes at room temperature to block nonspecific binding sites.
The cells were then rinsed for 5 minutes in PBS and incubated with primary antibodies against the NMDA receptor subunits NR I, NR2A, and NR2B and the AMP A receptor subunits GluRl, GluR2/3, and GluR4 for 1 hour at room temperature.
All antibodies were purchased from Upstate Biotechnology 
RT-PCR detection of glutamate receptor subunits
Reverse transcriptase polymerase chain reaction was used to determine the mRNA expression profile of the glutamate NMDA receptor subunits NR1, NR2A, NR2B, and NR2C, the AMPA receptor subunits GluRI, GluR2, GluR3, and GluR4, and the kainate receptor subunits KAI or KA2, GluR5, GluR6, and GluR7 in freshly isolated rat and human brain microves sels, cultured rat and human CEC, and cultured rat neurons. shown to be essential for establishing a functional NMDA receptor (Ishii et aI., 1993) , is shown in Fig. 4A .
Similarly, both rat and human CEC lacked immunoreac-o 1ilE'
Il:: C (1)0 000 Ct"') (1)-- Endothelin-1 (10 nmol/L; ET-1), angiotensin II (200 nmol/L; Ag II), or bradykinin (20 jJmol/L; BK) was added after the addition of glutamate receptor agonists to ensure that the cells were responsive. Rat cortical neurons were stimulated with 40 jJmol/L NMOA (E). The arrows indicate the times of addition of the specified agents. The results are tracings of typical responses replicated as described in the text. Also see text for abbreviations.
tivity for NR2A and NR2B subunits (data not shown) or AMPA GluRl, GluR2/3, and GluR4 subunits (data not shown). By contrast, cortical neurons (14 to 18 days in culture) expressed strong immunofluorescent staining for NRl, NR2A, NR2B, GluRl, and GluR2/3 ( Fig. 4) sub units associated predominately with the cell bodies and were negative for the GluR4 subunit (Fig. 4B) . Negative results were also seen in control cells in which the pri mary antibody had been omitted (Fig. 4B) we used the RT-PCR technique to assay for the presence of mRNA encoding various NMDA, AMP A, and kainate glutamate receptor subunits in rat or human CEC cul tures and rat neurons. We were not able to detect mRNA for either NMDA NRI1XX' NRloxx, NR2A, NR2B, or NR2C receptor subunits or AMPA GluRl, GluR2, GluR3, or GluR4 receptor subunits in any of the rat or human CEC cultures tested (Fig. 5) . The lack of these glutamate receptor subunits was confirmed in both hu man ( Fig. 5) for NMDA or AMPA receptor subunits was detected (Fig. 5) .
The sensitivity of the primer sets was assessed using a dilution series of the full-length clones for the various subunits. The sensitivity of the primer sets was such that the GluRl to GluR4 primer set detected as few as 10 3 copies, the NRI primer set detected as few as 10 4 copies, and the NR2A to NR2C primer set detected as few as 10 3 copies (data not shown). To establish whether our inabil ity to detect NMDA and AMPA receptor subunit mes sage in the CEC cultures was due to extracting insuffi cient quantities of RNA from these preparations, each preparation was probed with a primer set specific for a ubiquitously expressed enzyme, glyceraldehyde-3phosphate dehydrogenase (GAPDH), using primers GGAGATTGTTGCCATCAACGAC and ATGAGC CCTTCCACAATGCCAAAG. Each preparation probed was positive for GAPDH, suggesting that there was suf ficient RNA extracted from the cultures (Fig. 5, top) .
Primary rat cortical neuronal cultures were probed for glutamate receptor subunit mRNAs as positive controls.
The lack of NMDA and AMPA receptor expression ob served in the CEC cultures was in stark contrast to RT PCR assays performed on the neuronal cultures, in which both AMP A and NMDA receptor subunits were detected ( Fig. 5) . Although the NR11XX splice variants were de tected when probing message that had been pooled from four or more dishes of neurons (data not shown), the predominant splice variants expressed in the rat cortical neurons were those lacking the N-terminal NR10xx (Fig.   5, top) . The mRNA encoding NR2 (Fig. 5, middle) and
GluRl to GluR3 (Fig. 5, bottom) (Fig. 6) , GluR6, and GluR7 (data not shown) subunit mRNA were all detected in rat cortical cultures.
The specificity of the primers for rat kainate receptor subunits prevented probing human CEC, but the failure to observe any functional responses to very high concen trations of kainate or AMP A in either the rat or the human microvascular or capillary CEC (Fig. 1) suggests
..., � - The effect of the metabotropic glutamate receptor agonist 1 S.3R-tran�ACPD on IP3 (A to C) and cyclic AMP (0 to F) levels in rat (A and D) and human (6, E) CEC and rat cortical neurons (C and F) in culture. To determine IP3 accumulation, rat or human CEC or rat cortical neurons were prelabeled with [ 3 Hlmyo-inositol (20.5 Ci/mmol, 2. 5 mCi/mL) for 18 hours as described in Materials and Methods. Drug solvent (Con) or 300 Ilmoi/L 1 S.3R-tran�ACPD (t-ACPD) or 20 nmol/L endothelin-1 was added to the cultures for 15 minutes in the presence of 20 mmol/L LiCI 2 . IP3 was extracted and quantified as described in Materials and Methods. To measure cyclic AMP levels, rat or human CEC or rat cortical neurons were treated with the indicated concentrations of 1 S.3R-tran�ACPD with (shaded bars) or without (open bars) 1 Ilmoi/L forskolin for 10 minutes in the presence of 1 mmol/L 3-isobutyl-1-methylxanthine. Cyclic AMP levels were determined as described in Materials and Methods. Each bar represents the mean ± SO of four replicate dishes in one of three experiments yielding similar results. 'Significant differences (analysis of variance; P< 0.01) from control levels. #Significant difference as compared with forskolin (analysis of variance; P < 0.01) alone. See text for abbreviations. that the KAl, KA2, and GluR5 subunit mRNA expres sion is either not translated or is posttranslationally modified to render nonfunctional receptors.
DISCUSSION
This study provides evidence that endothelial cells of cerebral microvessels and capillaries in rat or human do not express functional glutamate receptors. This conclu sion is corroborated by the following experimental find- 
GluRI-4 (Busija and Leffler, 1989; Faraci and Breese, 1993) , they had no effect on isolated cerebral vessels in vitro (Fujiwara et aI., 1975; Swan et aI., 1988; Hardebo et aI., 1989; Takayasu and Dacey, 1989; Faraci and Breese, 1993; Wendling et aI., 1996) , indicating that this vasomotor response was not induced by direct action of glutamate on vascular cellular elements. In support of this view, it has been suggested that the NMDA-induced dilation of cerebral vessels is mediated by nitric oxide released as a result of neuronal activation (Faraci and Breese, 1993; Meng et aI., 1995) , since it could be inhibited by the nitric oxide synthase inhibitor AP -nitro-L-arginine (Faraci and Brian, 1995; Meng et aI., 1995) . that isolated bovine (Wendling et al., 1996) and ovine cerebral microvessels (Beart et aI., 1988) lack binding sites for NMDA antagonists. However, we cannot ex clude the possibility that endothelium or other cellular elements of larger cerebral vessels may express gluta mate receptors, since porcine cerebral arteries have been found to express specific radioligand binding sites for the noncompetitive NMDA receptor antagonist phencycli dine (Lu et aI., 1989) .
The finding that capillary CEC do not express func and synaptic complexes (Koenig et aI., 1992) . These studies were based largely on indirect evidence of glu tamate being able to activate a polyamine metabolic cas cade known to be stimulated by various other diffusible biochemical stimuli including arachidonic acid (Chan et aI., 1983; Pappius and Wolfe, 1983) , prostaglandins (Pappius and Wolfe, 1983), diacylglycerol (Politi et aI., 1985) , and free oxygen radicals (Chan et aI., 1984) .
Therefore, these results are difficult to reconcile with the evidence presented in this study of the absence of NMDA and other glutamate receptors in both cultured endothelial cells and freshly isolated microvessels. The discrepancy between the two studies may be explained by a possible non-receptor-mediated action of glutamate or NMDA on CEC or by the unlikely presence of "atypi cal" NMDA receptors in CEC that we were not able to detect by the methods used. Nevertheless, based on our data, it appears highly unlikely that glutamate is capable of affecting BBB opening by acting directly on cerebral capillary endothelial cells. Therefore, it appears that glu tamate involvement in BBB opening during pathological events that stimulate glutamate release such as stroke, brain trauma, and epilepsy is largely caused by the para crine effects of secondary mediators stimulated and re leased by surrounding glutamate receptor-expressing cells. The nature of these secondary mediators is pres ently unknown but may include compounds such as re active oxygen species, eicosanoids, polyamines, and ni tric oxide, all of which have been shown to induce BBB opening in vivo and/or in vitro (Black, 1995) .
In conclusion, our results demonstrate the absence of functional glutamate receptor expression in rat and hu man microvascular and capillary CEC and suggest that glutamate, even at the high extracellular concentrations found in cerebral ischemia (Hagberg et aI., 1987) , is unlikely to affect microvessel tone or BBB permeability by acting directly on endothelial cells. Therefore, the neuroprotective effects of glutamate receptor antagonists developed for the clinical treatment of epilepsy, stroke, and head injury (Muir and Lees, 1995) are apparently not mediated through sites of action on cerebral microves sels.
